Edwards Lifesciences specializes in heart valve innovations and critical care monitoring, competing with giants like Medtronic and Boston Scientific.Chopra Daveen, CVP of TMTT & Surgical at Edwards, sold 2,000 shares, indicating strategic decisions amidst growth initiatives.The company is focused on sustainable growth, particularly in therapies for structural heart conditions, with a current market capitalization of approximately $49.46 billion.Edwards Lifesciences Corporation (NYSE: EW) is a prominent play ...